Does strategic approach for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers?
Iontophoresis and combination with SDGC were found to be safe and potential strategies for transbuccal peptide delivery in vivo.
In a comprehensive study of the causes of bilateral hearing loss in young French children, cCMV is the second most frequent cause of hearing loss after connexin mutations. It underlines that a majority of French children with hearing loss and cCMV are not diagnosed early and therefore may not benefit from early intervention including the possibility of neonatal antiviral treatment. These results make the case for promoting systematic cytomegalovirus screening in neonates with confirmed hearing loss identified through neonatal hearing screening.